The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Critical Care Therapeutics-Global Market Insights and Sales Trends 2025
Synopsis
The global Critical Care Therapeutics market size is expected to reach US$ 3503.9 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029. The market is mainly driven by the significant applications of Critical Care Therapeutics in various end use industries. The expanding demands from the Pulmonary Embolism (PE), Acute Coronary Syndrome, Atrial Fibrillation and Other, are propelling Critical Care Therapeutics market. Albumin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Prothrombin Complex Concentrates segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Critical Care Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Critical Care Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Critical Care Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Critical Care Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Critical Care Therapeutics covered in this report include CSL Behring, Grifols, Kedrion Biopharma, Octapharma, Takeda, Bayer HealthCare, Merck, Mitsubishi Tanabe Pharma and REVO Biologics, etc.
The global Critical Care Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CSL Behring
Grifols
Kedrion Biopharma
Octapharma
Takeda
Bayer HealthCare
Merck
Mitsubishi Tanabe Pharma
REVO Biologics
Rockwell Medical
Thermo Fisher Scientific
Shanghai RAAS
China Biologic Products
Cosmo Pharmaceuticals
King Pharmaceuticals
Global Critical Care Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Critical Care Therapeutics market, Segment by Type:
Albumin
Prothrombin Complex Concentrates
Antithrombin Concentrates
Factor XIII Concentrates
Fibrinogen Concentrates
Global Critical Care Therapeutics market, by Application
Pulmonary Embolism (PE)
Acute Coronary Syndrome
Atrial Fibrillation
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Critical Care Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Critical Care Therapeutics market size is expected to reach US$ 3503.9 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029. The market is mainly driven by the significant applications of Critical Care Therapeutics in various end use industries. The expanding demands from the Pulmonary Embolism (PE), Acute Coronary Syndrome, Atrial Fibrillation and Other, are propelling Critical Care Therapeutics market. Albumin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Prothrombin Complex Concentrates segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Critical Care Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Critical Care Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Critical Care Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Critical Care Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Critical Care Therapeutics covered in this report include CSL Behring, Grifols, Kedrion Biopharma, Octapharma, Takeda, Bayer HealthCare, Merck, Mitsubishi Tanabe Pharma and REVO Biologics, etc.
The global Critical Care Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CSL Behring
Grifols
Kedrion Biopharma
Octapharma
Takeda
Bayer HealthCare
Merck
Mitsubishi Tanabe Pharma
REVO Biologics
Rockwell Medical
Thermo Fisher Scientific
Shanghai RAAS
China Biologic Products
Cosmo Pharmaceuticals
King Pharmaceuticals
Global Critical Care Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Critical Care Therapeutics market, Segment by Type:
Albumin
Prothrombin Complex Concentrates
Antithrombin Concentrates
Factor XIII Concentrates
Fibrinogen Concentrates
Global Critical Care Therapeutics market, by Application
Pulmonary Embolism (PE)
Acute Coronary Syndrome
Atrial Fibrillation
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Critical Care Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Critical Care Therapeutics
1.1 Critical Care Therapeutics Market Overview
1.1.1 Critical Care Therapeutics Product Scope
1.1.2 Critical Care Therapeutics Market Status and Outlook
1.2 Global Critical Care Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Critical Care Therapeutics Market Size by Region (2018-2029)
1.4 Global Critical Care Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Critical Care Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Critical Care Therapeutics Market Size (2018-2029)
1.6.1 North America Critical Care Therapeutics Market Size (2018-2029)
1.6.2 Europe Critical Care Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Critical Care Therapeutics Market Size (2018-2029)
1.6.4 Latin America Critical Care Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Critical Care Therapeutics Market Size (2018-2029)
2 Critical Care Therapeutics Market by Type
2.1 Introduction
2.1.1 Albumin
2.1.2 Prothrombin Complex Concentrates
2.1.3 Antithrombin Concentrates
2.1.4 Factor XIII Concentrates
2.1.5 Fibrinogen Concentrates
2.2 Global Critical Care Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Critical Care Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Critical Care Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Critical Care Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Critical Care Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Critical Care Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Critical Care Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Critical Care Therapeutics Revenue Breakdown by Type (2018-2029)
3 Critical Care Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Pulmonary Embolism (PE)
3.1.2 Acute Coronary Syndrome
3.1.3 Atrial Fibrillation
3.1.4 Other
3.2 Global Critical Care Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Critical Care Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Critical Care Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Critical Care Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Critical Care Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Critical Care Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Critical Care Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Critical Care Therapeutics Revenue Breakdown by Application (2018-2029)
4 Critical Care Therapeutics Competition Analysis by Players
4.1 Global Critical Care Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Critical Care Therapeutics as of 2022)
4.3 Date of Key Players Enter into Critical Care Therapeutics Market
4.4 Global Top Players Critical Care Therapeutics Headquarters and Area Served
4.5 Key Players Critical Care Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Critical Care Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 CSL Behring
5.1.1 CSL Behring Profile
5.1.2 CSL Behring Main Business
5.1.3 CSL Behring Critical Care Therapeutics Products, Services and Solutions
5.1.4 CSL Behring Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 CSL Behring Recent Developments
5.2 Grifols
5.2.1 Grifols Profile
5.2.2 Grifols Main Business
5.2.3 Grifols Critical Care Therapeutics Products, Services and Solutions
5.2.4 Grifols Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Grifols Recent Developments
5.3 Kedrion Biopharma
5.3.1 Kedrion Biopharma Profile
5.3.2 Kedrion Biopharma Main Business
5.3.3 Kedrion Biopharma Critical Care Therapeutics Products, Services and Solutions
5.3.4 Kedrion Biopharma Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Octapharma Recent Developments
5.4 Octapharma
5.4.1 Octapharma Profile
5.4.2 Octapharma Main Business
5.4.3 Octapharma Critical Care Therapeutics Products, Services and Solutions
5.4.4 Octapharma Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Octapharma Recent Developments
5.5 Takeda
5.5.1 Takeda Profile
5.5.2 Takeda Main Business
5.5.3 Takeda Critical Care Therapeutics Products, Services and Solutions
5.5.4 Takeda Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Takeda Recent Developments
5.6 Bayer HealthCare
5.6.1 Bayer HealthCare Profile
5.6.2 Bayer HealthCare Main Business
5.6.3 Bayer HealthCare Critical Care Therapeutics Products, Services and Solutions
5.6.4 Bayer HealthCare Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Bayer HealthCare Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Critical Care Therapeutics Products, Services and Solutions
5.7.4 Merck Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 Mitsubishi Tanabe Pharma
5.8.1 Mitsubishi Tanabe Pharma Profile
5.8.2 Mitsubishi Tanabe Pharma Main Business
5.8.3 Mitsubishi Tanabe Pharma Critical Care Therapeutics Products, Services and Solutions
5.8.4 Mitsubishi Tanabe Pharma Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Mitsubishi Tanabe Pharma Recent Developments
5.9 REVO Biologics
5.9.1 REVO Biologics Profile
5.9.2 REVO Biologics Main Business
5.9.3 REVO Biologics Critical Care Therapeutics Products, Services and Solutions
5.9.4 REVO Biologics Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 REVO Biologics Recent Developments
5.10 Rockwell Medical
5.10.1 Rockwell Medical Profile
5.10.2 Rockwell Medical Main Business
5.10.3 Rockwell Medical Critical Care Therapeutics Products, Services and Solutions
5.10.4 Rockwell Medical Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Rockwell Medical Recent Developments
5.11 Thermo Fisher Scientific
5.11.1 Thermo Fisher Scientific Profile
5.11.2 Thermo Fisher Scientific Main Business
5.11.3 Thermo Fisher Scientific Critical Care Therapeutics Products, Services and Solutions
5.11.4 Thermo Fisher Scientific Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Thermo Fisher Scientific Recent Developments
5.12 Shanghai RAAS
5.12.1 Shanghai RAAS Profile
5.12.2 Shanghai RAAS Main Business
5.12.3 Shanghai RAAS Critical Care Therapeutics Products, Services and Solutions
5.12.4 Shanghai RAAS Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Shanghai RAAS Recent Developments
5.13 China Biologic Products
5.13.1 China Biologic Products Profile
5.13.2 China Biologic Products Main Business
5.13.3 China Biologic Products Critical Care Therapeutics Products, Services and Solutions
5.13.4 China Biologic Products Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 China Biologic Products Recent Developments
5.14 Cosmo Pharmaceuticals
5.14.1 Cosmo Pharmaceuticals Profile
5.14.2 Cosmo Pharmaceuticals Main Business
5.14.3 Cosmo Pharmaceuticals Critical Care Therapeutics Products, Services and Solutions
5.14.4 Cosmo Pharmaceuticals Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.14.5 Cosmo Pharmaceuticals Recent Developments
5.15 King Pharmaceuticals
5.15.1 King Pharmaceuticals Profile
5.15.2 King Pharmaceuticals Main Business
5.15.3 King Pharmaceuticals Critical Care Therapeutics Products, Services and Solutions
5.15.4 King Pharmaceuticals Critical Care Therapeutics Revenue (US$ Million) & (2018-2023)
5.15.5 King Pharmaceuticals Recent Developments
6 North America
6.1 North America Critical Care Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Critical Care Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Critical Care Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Critical Care Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Critical Care Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Critical Care Therapeutics Market Dynamics
11.1 Critical Care Therapeutics Industry Trends
11.2 Critical Care Therapeutics Market Drivers
11.3 Critical Care Therapeutics Market Challenges
11.4 Critical Care Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
